In ATTR-CM, significant VHD is strongly associated with poor prognosis, with the highest risk for adverse events in significant multiple VHD including AS, including aortic stenosis.
C. Sarrazyn, P. Debonnaire, Mathias Claeys et al.· Amyloid: Journal of Protein...· 0 citations
Dilated cardiomyopathy (DCM) is a major cause of heart failure and sudden cardiac death, characterized by left ventricular dilation and systolic dysfunction in the absence of significant coronary or valvular disease. Although traditionally viewed as an idiopathic condition, DCM is now recognized as a genetically driven...
Roxana-Daniela Delcea, R. Jurcuț, S. Militaru et al.· Biomedicines· 0 citations
This review paper aims to provide a structured and evidence-informed framework to guide personalized management of DCM and NDLVC, starting from the phenotype towards precision medicine.
R. D. de Boer, A. Chaloupka, Bethan Cowley et al.· European Journal of Heart Fa...· 0 citations
Current evidence on TAVI for native AR focuses on devices, procedural performance, complications, and outcomes, and presents a 24-year-old man with MYH7-associated hypertrophic obstructive cardiomyopathy and severe post-myectomy AR complicated by biventricular failure, cardiogenic shock, and multiorgan dysfunction.
C. Parasca, D. Deleanu, P. Platon et al.· Life· 0 citations
In this international multicenter study, the largest to date, including >3300 consecutive patients with HCM and ICDs, device therapy terminated potentially lethal ventricular tachyarrhythmias in 1 of 6 patients, with low HCM-related mortality rates for patients with ICDs.
E. Rowin, B. J. Maron, K. Siontis et al.· Circulation· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.